Scarica l'app Stockscreener
0.00
100.00%
-14.84
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ETNB Giù?
Forum
Previsione
Precedente Chiudi:
$14.84
Aprire:
$0
Volume 24 ore:
0
Relative Volume:
0.00
Capitalizzazione di mercato:
$2.20B
Reddito:
-
Utile/perdita netta:
$-174.61M
Rapporto P/E:
0.00
EPS:
-1.97
Flusso di cassa netto:
$-165.54M
1 W Prestazione:
-100.00%
1M Prestazione:
-100.00%
6M Prestazione:
-100.00%
1 anno Prestazione:
-100.00%
Intervallo 1D:
$0.00
$0.00
Intervallo di 1 settimana:
$0.00
$0.00
Portata 52W:
$0.00
$15.06
89 Bio Inc Stock (ETNB) Company Profile
Nome
89 Bio Inc
Settore
Industria
Telefono
(415) 432-9270
Indirizzo
655 MONTGOMERY STREET, SAN FRANCISCO, CA
Confronta ETNB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ETNB
89 Bio Inc
|
0.00 | 2.20B | 0 | -174.61M | -165.54M | -1.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.20 | 103.89B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
654.74 | 69.11B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
441.70 | 58.49B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
869.83 | 52.62B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
191.92 | 40.46B | 447.02M | -1.18B | -906.14M | -6.1812 |
89 Bio Inc Stock (ETNB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-04 | Ripresa | H.C. Wainwright | Buy |
| 2025-03-14 | Iniziato | Goldman | Neutral |
| 2025-03-13 | Iniziato | Citigroup | Buy |
| 2025-02-04 | Iniziato | Wolfe Research | Outperform |
| 2024-04-22 | Ripresa | BofA Securities | Buy |
| 2024-01-12 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-10 | Downgrade | Oppenheimer | Outperform → Perform |
| 2023-08-28 | Iniziato | UBS | Buy |
| 2023-06-13 | Iniziato | Evercore ISI | Outperform |
| 2022-05-12 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2021-12-20 | Iniziato | H.C. Wainwright | Buy |
| 2021-10-26 | Ripresa | Cantor Fitzgerald | Overweight |
| 2021-07-29 | Ripresa | BTIG Research | Buy |
| 2021-05-25 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2021-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-10-19 | Iniziato | Raymond James | Strong Buy |
| 2020-09-25 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-07-31 | Iniziato | Piper Sandler | Overweight |
| 2020-07-23 | Iniziato | BTIG Research | Buy |
| 2020-07-07 | Iniziato | Chardan Capital Markets | Buy |
| 2019-12-09 | Iniziato | BofA/Merrill | Neutral |
| 2019-12-09 | Iniziato | Oppenheimer | Outperform |
| 2019-12-09 | Iniziato | RBC Capital Mkts | Outperform |
| 2019-12-09 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
89 Bio Inc Borsa (ETNB) Ultime notizie
[Form 4] 89bio, Inc. Insider Trading Activity - Stock Titan
ETNB CEO Form 4 details Roche deal payout and option treatment - Stock Titan
ETNB officer reports tender offer completion; shares exchanged for $14.50 + CVR - Stock Titan
[POSASR] 89bio, Inc. SEC Filing - Stock Titan
Roche Holdings completes acquisition of 89bio and delists company from Nasdaq - Investing.com
Roche completes 89bio deal; ETNB holders get $14.50 cash + CVR - Stock Titan
89bio acquired by Roche with $14.50 cash and up to $6 CVR - Stock Titan
Roche (OTCQX: RHHBY) accepts 60.49% of 89bio shares, plans merger at $14.50 + CVR - Stock Titan
Roche purchases shares in tender offer for 89bio, Inc - The Manila Times
89bio, Inc.(NasdaqGM: ETNB) dropped from S&P Biotechnology Select Industry Index - MarketScreener
ETNB CFO option exercises update direct holdings to 339,295 shares - Stock Titan
How strong is 89bio Inc. stock balance sheetEarnings Risk Summary & Fast Moving Stock Watchlists - Trung tâm Dự báo KTTV quốc gia
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: 89bio, Inc. (NasdaqETNB), Barinthus Biotherapeutics plc (NasdaqBRNS), Verint Systems Inc. (Nasdaq - GlobeNewswire Inc.
Combining price and volume data for 89bio Inc.Layoff News & Long-Term Growth Stock Strategies - newser.com
Will 89bio Inc. stock benefit from AI adoption2025 Geopolitical Influence & Weekly Top Performers Watchlists - newser.com
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
89bio, Inc. (ETNB) Stock Analysis: Unveiling A 97% Potential Upside In The Biotech Sector - DirectorsTalk Interviews
Janus Henderson Reports 5,378,185 Shares, 3.6% Stake in 89bio - Stock Titan
89bio Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 89bio, Inc.ETNB - Business Wire
Investors Purchase High Volume of Put Options on 89BIO (NASDAQ:ETNB) - Defense World
After courting 14 pharmas, 89bio was left between a Roche and hard place in buyout talks - Fierce Biotech
Roche commences tender offer for all shares of 89bio, Inc. - GlobeNewswire
$20.50 Per Share Deal: Roche Makes Move to Acquire 89bio in Major Biotech Tender Offer - Stock Titan
89bio, Inc. (ETNB) Shareholders to Receive Up to $3.5B Total in Roche Buyout Deal - MSN
Roche Initiates Tender Offer for 89bio (ETNB) in $3.5B Acquisiti - GuruFocus
Kala Bio Stock Just Plunged 89% Today – Here’s What Happened - Stocktwits
Why 89bio Inc. stock is rated strong buy2025 Biggest Moves & Verified Entry Point Detection - newser.com
Technical analysis overview for 89bio Inc. stock2025 Short Interest & Growth Oriented Trading Recommendations - newser.com
Will 89bio Inc. stock split attract more investorsWeekly Trend Recap & Daily Profit Maximizing Trade Tips - newser.com
Is 89bio Inc. stock attractive for retirement portfoliosWeekly Stock Report & Momentum Based Trading Ideas - newser.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PINC, MTSR, ETNB on Behalf of Shareholders - GlobeNewswire Inc.
Backtesting results for 89bio Inc. trading strategiesQuarterly Trade Review & Short-Term High Return Strategies - newser.com
How 89bio Inc. stock reacts to global recession fearsBear Alert & Community Consensus Picks - newser.com
Measuring 89bio Inc.’s beta against major indicesEarnings Overview Report & Daily Profit Maximizing Trade Tips - newser.com
89bio, Inc. Hits New 52-Week High of $15.06, Up 76.62% - Markets Mojo
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of 89bio, Inc. (NASDAQ: ETNB) - PR Newswire
How to integrate 89bio Inc. into portfolio analysis toolsJuly 2025 EndofMonth & Weekly Top Gainers Alerts - newser.com
Applying chart zones and confluence areas to 89bio Inc.Forecast Cut & Free Technical Pattern Based Buy Signals - newser.com
Real time breakdown of 89bio Inc. stock performance2025 Historical Comparison & Entry Point Strategy Guides - newser.com
Roche To Buy 89bio For Up To $3.5 Billion - Pulse 2.0
89Bio (ETNB) Soars 86 Percent to Historic High on $3.5-Billion Roche Merger - MSN
Will 89bio Inc. continue its uptrendPortfolio Update Summary & Verified High Yield Trade Plans - newser.com
Published on: 2025-09-19 14:02:20 - newser.com
Has 89bio Inc. found a price floor2025 Market Trends & Technical Confirmation Trade Alerts - newser.com
89bio Stock Price, Quotes and Forecasts | NASDAQ:ETNB - Benzinga
89BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 89bio, Inc.ETNB - Business Wire
Dow Update: Is 89bio Inc trading at a discountWeekly Trade Analysis & Reliable Price Breakout Alerts - خودرو بانک
Roche to Buy 89bio for Up to $3.5 Billion in Obesity Push - MSN
Wolfe Research downgrades 89bio stock rating to Peerperform after acquisition news - Investing.com
89 Bio Inc Azioni (ETNB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
89 Bio Inc Azioni (ETNB) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Le-Nguyen Quoc | See Remarks |
Jul 15 '25 |
Sale |
11.02 |
10,461 |
115,280 |
309,364 |
0.05%
1.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):